These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 268183)

  • 21. Amikacin therapy of severe infections produced by gram-negative bacilli resistant to gentamicin.
    Valdivieso M; Bodey GP
    Am J Med Sci; 1977; 273(2):177-84. PubMed ID: 860733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections.
    Sharp PM; Saenz CA; Martin RR
    Antimicrob Agents Chemother; 1974 May; 5(5):435-8. PubMed ID: 4462458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proteus rettgeri strains, resistant to gentamicin with transmissible resistance to kanamycin and carbenicillin (author's transl)].
    Urbàsková P; Torsová V; Dostàl J; Huśłavová V; Krcméry V
    Cesk Epidemiol Mikrobiol Imunol; 1977 May; 26(3):171-4. PubMed ID: 144028
    [No Abstract]   [Full Text] [Related]  

  • 24. [[Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]?].
    Shibata K; Fugii M; Shinagawa N; Suzuki Y; Muramatsu
    Jpn J Antibiot; 1974 Oct; 27(5):625-32. PubMed ID: 4218270
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.
    Zinner SH; Provonchee RB; Elias KS; Peter G
    Antimicrob Agents Chemother; 1976 Apr; 9(4):661-4. PubMed ID: 817663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 28. [Amikacin: a new semisynthetic aminoside antibiotic derivative of kanamycin A. Action spectrum].
    Periti P; Lamanna A; Nicoletti I; Mazzei T; Polito P
    G Ital Chemioter; 1975; 22(1-2):75-86. PubMed ID: 1235358
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.
    Kabins SA; Nathan C
    Antimicrob Agents Chemother; 1978 Nov; 14(5):786-7. PubMed ID: 727766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gentamicin/amikacin-resistant gram-negative bacilli at Detroit General Hospital, 1975-1976.
    Jauregui L; Cushing RD; Lerner AM
    Am J Med; 1977 Jun; 62(6):882-8. PubMed ID: 868902
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and bacteriological evaluation of Amikin (Amikacin sulfate) by Bristol-Myers].
    Wencel J; Czaplicki M; Borkowski A; Malewski AW
    Pol Tyg Lek; 1978 Dec; 33(50):1937-8. PubMed ID: 733620
    [No Abstract]   [Full Text] [Related]  

  • 32. Amikacin.
    Gleckman R
    Am Fam Physician; 1976 Dec; 14(6):75. PubMed ID: 998471
    [No Abstract]   [Full Text] [Related]  

  • 33. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    Tomioka H; Kobayashi Y; Tamatani S; Morishita T; Hasegawa Y
    Jpn J Antibiot; 1975 Jun; 28(3):305-8. PubMed ID: 807757
    [No Abstract]   [Full Text] [Related]  

  • 35. Amikacin.
    Lancet; 1975 Oct; 2(7939):804-5. PubMed ID: 78162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resistance to amikacin of gentamicin-resistant Staphylococcus aureus].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Debusschere P; Crokaert F
    Acta Clin Belg; 1980; 35(6):384-5. PubMed ID: 7331667
    [No Abstract]   [Full Text] [Related]  

  • 37. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant Proteus rettgeri: an emerging problem.
    Iannini PB; Eickhoff TC; LaForce FM
    Ann Intern Med; 1976 Aug; 85(2):161-4. PubMed ID: 1047989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of amikacin and gentamicin.
    Klastersky J; Odio W; Hensgens C
    Clin Pharmacol Ther; 1975 Mar; 17(3):348-54. PubMed ID: 804370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.